The Discounted Cash Flow (DCF) valuation of Tanke Biosciences Corp (TNBI) is 0.26 USD. With the latest stock price at 0.04 USD, the upside of Tanke Biosciences Corp based on DCF is 505.4%.
Based on the latest price of 0.04 USD and our DCF valuation, Tanke Biosciences Corp (TNBI) is a buy. buying TNBI stocks now will result in a potential gain of 505.4%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 71.3% | 38.8% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 0.09 - 2.48 | 0.26 |
| Upside | 113.2% - 5750.9% | 505.4% |